On November 23, 2016, Livzon Pharmaceutical Group Inc. was awarded the Most Growable Listed Company at the 6th China Securities Golden Bauhinia Award. This is the first time that the Company won an honor in the Hong Kong capital market since it was listed on the main board of the Hong Kong market in January 2014.

The 6^th China Securities Golden Bauhinia Award has 11 categories of awards, such as “The Most Influential Listed Company Leader,” “The Best Listed Company CEO,” “The Best Investment Value Award for Listed Companies, and “The Most Growable Listed Company.”

The China Securities Golden Bauhinia Award is a leading award in Hong Kong, which comprehensively evaluates listed companies in Hong Kong and the PRC annually. Enterprises and management with outstanding performance are recognized every year as role models of the industry.

Mr. Yang Liang, Secretary of the Board of Directors of Livzon Pharmaceutical Group Inc., received the awards at the ceremony.

The Livzon Pharmaceutical Group is dedicated to the improvement of human life and health, and the company has received many awards and recognitions. Over the past 3 years, the Livzon Pharmaceutical Group has grown rapidly. The company was relocated to the highly modernized Livzon Industrial Park in 2016, and has been strategically transforming itself into a bio-pharmaceuticals enterprise. The award not only represents recognition of the company’s effort, but also enhances the company’s corporate image, as well as improving its brand awareness and impact in the international capital market.